// App-Quantinova.ai

: Prophylaxis of Chemotherapy-Induced Nausea and Vomiting with Fosaprepitant and Granisetron in Pediatric Patients after Allogeneic HSCT

Researchers

Presenter

  • Karin Melanie Cabanillas Stanchi

Principal Investigators

  • Julia Vek

  • Patrick Schlegel

  • Christian M. Seitz

  • Joachim Rupprecht

  • Sarah Schober

  • Sebastian Michaelis

  • Carmen Malaval

  • Tim Flaadt

  • Lukas Schnaufer

  • Manon Queudeville

  • Judith Feucht

  • Peter Lang

  • Rupert Handgretinger

  • Michaela Dring

Medical Centers

  • Dpt. I - General Pediatrics, Hematology and Oncology,University Children's Hospital Tübingen,Tübingen,Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Ophthalmology (OP)

  • Blood/haematological Diseases

  • Genetic Disorder

Disease

  • Chemotherapy-induced nausea and vomiting

  • Acute lymphoblastic leukemia

  • Myelodysplastic Syndrome

  • Acute myelocytic leukemia

  • Non-Hodgkin's Lymphoma

  • Hodgkin's Lymphoma

  • Sickle cell anemia

  • Beta-thalassemia

  • Acute Leukemia

  • Neuroblastoma

  • Solid malignancies

  • Brain cancer

  • Thalassemia

  • Non‐Hodgkin Lymphoma

  • Lymphomas

  • Anemia

Biomarkers

  • Legumain

Drug/Treatment

  • Dimenhydrinate

  • Fosaprepitant

  • granisetron tablet

  • Aprepitant

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved